A randomized, double-blind, placebo-controlled trial of metformin in reducing progression among men on expectant management for low-risk prostate cancer: The MAST (Metformin Active Surveillance Trial) study Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Fleshner, Neil E
  • Bernardino, Rui Miguel
  • Lajkosz, Katherine
  • Saad, Fred
  • Izawa, Jonathan
  • Drachenberg, Darrel
  • Saranchuk, Jeff W
  • Tanguay, Simon
  • Rendon, Ricardo A
  • Leveridge, Michael
  • Shayegan, Bobby
  • Fairey, Adrian
  • Cockburn, Jessica Grace
  • Berlin, Doron
  • Hamilton, Robert James
  • Sildva, Tiiu
  • Breau, Rodney H
  • Richard, Patrick O
  • Klotz, Laurence
  • Joshua, Anthony M

publication date

  • June 10, 2024